Meyka AI API is live for developers.Start building.
Advertisement
Jazz Pharmaceuticals plc

Jazz Pharmaceuticals plc (JAZZ) Stock Overview

Explore Jazz Pharmaceuticals plc’s financial performance, market position, analyst ratings, and future outlook.

JAZZ●NASDAQ
HealthcareBiotechnology
$238.57
$1.49(0.62%)
U.S. Market opens in 45h 14m
Advertisement

Jazz Pharmaceuticals plc (JAZZ)

Meyka AI Score

Z

Key Financials

Market Cap15B
P/E Ratio499.37
EPS (TTM)$0.11
ROE0.01%
Fundamental Analysis

AI Price Forecasts

1 Month$168.57
3 Months$169.46
1 Year Target$152.31

JAZZ Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Jazz Pharmaceuticals plc (JAZZ) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 64.16, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $152.31.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 499.37 and a market capitalization of 15B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-0.62%
5-Day Change
1.36%
1-Month Change
12.40%
3-Month Change
29.92%
6-Month Change
40.58%
Year-to-Date (YTD) Change
40.34%
1-Year Change
119.27%
3-Year Change
83.90%
5-Year Change
35.19%
All-Time (Max) Change
1245.57%

Contact Information

https://www.jazzpharma.com
353 1 634 7800
Waterloo Exchange, Dublin, NaN, 4

Company Facts

2,800 Employees
IPO DateJun 1, 2007
CountryUS
Actively Trading

Frequently Asked Questions